| Literature DB >> 25786451 |
Jun Shiraishi1, Hidenori Koyama, Miwako Seki, Miki Hatayama, Mariko Naka, Masafumi Kurajoh, Hirokazu Okazaki, Takuhito Shoji, Yuji Moriwaki, Tetsuya Yamamoto, Yasuaki Tsuchida, Yoshitane Tsukamoto, Seiichi Hirota, Naoyoshi Onoda, Mitsuyoshi Namba.
Abstract
Anaplastic thyroid carcinoma is a rare disease, and cases associated with eosinophilia are even rarer. We herein report a case of anaplastic thyroid carcinoma accompanied by remarkable and uncontrollable eosinophilia. A 71-year-old man was diagnosed with end-stage anaplastic thyroid carcinoma. Throughout the aggressive clinical course of the cancer, eosinophilia dramatically progressed and became extremely refractory to steroid treatment. We measured the serum levels of hematopoietic cytokines potentially involved in eosinophilia, including granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-3 and IL-5. Although the GM-CSF level was moderately elevated, both the IL-3 and IL-5 levels were within the normal ranges. In this case, the patient's eosinophilia may have been related to his severe dyspnea and was likely responsible for the allergic reaction to the anticancer drug. Therefore, it is essential to elucidate the etiology of eosinophilia in patients with thyroid cancer in order to improve the treatment for patients with anaplastic thyroid carcinoma.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25786451 DOI: 10.2169/internalmedicine.54.3446
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271